צמיחה צפויה ברווח למניה לשנה הבאה sensushealthcare.com (SRTS)
Sensus Healthcare, Inc. (SRTS) dominates the non-invasive skin cancer treatment niche with its compact SRT systems, although export restrictions and chip shortages are hindering expansion in Asia. The one-year forward EPS growth rate clearly illustrates analyst expectations, with the value fixed at 85.70. A narrow business profile in dermatology is balanced by steady earnings from service maintenance and consumables.
פילוחים אנליטיים של חברת sensushealthcare.com (SRTS)
Investors are assessing the financial stability of Sensus Healthcare, Inc. (SRTS) through its profit scaling potential. This indicator aggregates analyst consensus forecasts for earnings per share (EPS) changes, reflecting market expectations for business efficiency. By analyzing the trend of market expectations for EPS growth, one can understand how innovations in radiation therapy systems and the company's patents translate into concrete financial results for shareholders.
